115 related articles for article (PubMed ID: 6016296)
1. Erythema nodosum and contraceptive medication.
Matz MH
N Engl J Med; 1967 Feb; 276(6):351-2. PubMed ID: 6016296
[No Abstract] [Full Text] [Related]
2. [Pulmonary infarct during treatment with an oral contraceptive (norethylnodrel + mestranol)].
Hazard J; Modaï J; Moulin S; Vuagnat P; Domart A
Sem Hop; 1967 Mar; 43(15):991-3. PubMed ID: 4292991
[No Abstract] [Full Text] [Related]
3. Erythema nodosum from oral contraceptives.
Baden HP; Holcomb FD
Arch Dermatol; 1968 Dec; 98(6):634-5. PubMed ID: 5697233
[No Abstract] [Full Text] [Related]
4. Some apparently common problems in patients receiving contraceptive pills.
Ball P
Nebr State Med J; 1968 Sep; 53(9):428-32. PubMed ID: 4176717
[No Abstract] [Full Text] [Related]
5. Galactorrhea after contraceptive hormones.
Gregg WI
N Engl J Med; 1966 Jun; 274(25):1432. PubMed ID: 5949006
[No Abstract] [Full Text] [Related]
6. Pulmonary embolization and oral contraceptive.
Ferguson JN
JAMA; 1967 May; 200(6):560. PubMed ID: 6071459
[No Abstract] [Full Text] [Related]
7. Oral contraceptives and erythema nodosum.
Kirby JF; Kraft GH
Obstet Gynecol; 1972 Sep; 40(3):409-10. PubMed ID: 5054972
[No Abstract] [Full Text] [Related]
8. [Blood coagulation and oral ovulostatic steroids. (Case studies of 22 women treated for a long period, from 6 months to 3 years, with norethynodrel and mestranol)].
Conti M; Neglia V; Arrotta U
Minerva Ginecol; 1967 Nov; 19(22):1091-4. PubMed ID: 5606233
[No Abstract] [Full Text] [Related]
9. Erythema nodosum and oral contraception.
Kariher DH
Obstet Gynecol; 1973 Aug; 42(2):323-4. PubMed ID: 4721424
[No Abstract] [Full Text] [Related]
10. Cutaneous eruptions and in vitro lymphocyte hypersensitivity. Associated with oral contraceptives and mestranol.
Savel H; Madison JF; Meeker CI
Arch Dermatol; 1970 Feb; 101(2):187-90. PubMed ID: 5413254
[No Abstract] [Full Text] [Related]
11. Stroke and myocardial infarction in a patient taking oral contraceptives.
Szweda JA; Snook WH; Taake ER
Wis Med J; 1974 Feb; 73(2):S17-9. PubMed ID: 4816409
[No Abstract] [Full Text] [Related]
12. Oral contraceptives and intravenous glucose tolerance. II. Long-term effect.
Posner NA; Silverstone FA; Pomerance W; Singer N
Obstet Gynecol; 1967 Jan; 29(1):87-92. PubMed ID: 6017950
[No Abstract] [Full Text] [Related]
13. Norethynodrel with mestranol and venous blood flow.
Neistadt A; Schwartz RW; Schwartz SI
JAMA; 1966 Nov; 198(7):784-5. PubMed ID: 5953344
[No Abstract] [Full Text] [Related]
14. Strokes in young women using oral contraceptives.
Cole M
Arch Intern Med; 1967 Nov; 120(5):551-5. PubMed ID: 6054589
[No Abstract] [Full Text] [Related]
15. Oral-contraceptive-associated liver tumours.
Emerson QB; Nachtnebel KL; Penkava RR; Rothenberg J
Lancet; 1980 Jun; 1(8180):1251. PubMed ID: 6104064
[TBL] [Abstract][Full Text] [Related]
16. [Thrombolytic therapy of cerebral thrombosis caused by Infecundin].
Gaszner P; Herr G; Mezei B
Orv Hetil; 1974 Apr; 115(16):924-6. PubMed ID: 4821198
[No Abstract] [Full Text] [Related]
17. [Chloasmic type of pigmentation of the face during treatments with estrogens and progestational hormones].
Basset H
Bull Soc Fr Dermatol Syphiligr; 1967; 74(2):166-8. PubMed ID: 6061306
[No Abstract] [Full Text] [Related]
18. Polyneuritis and oral contraceptives.
Strang CD
Br Med J; 1965 Oct; 2(5466):879-80. PubMed ID: 5827807
[No Abstract] [Full Text] [Related]
19. Intravenous glucose tolerance after 18 months on progestogen or combination-type oral contraceptive.
Goldman JA
Isr J Med Sci; 1978 Mar; 14(3):324-7. PubMed ID: 640815
[TBL] [Abstract][Full Text] [Related]
20. [Thrombo-embolic cases in gestagen-estrogen-treated patients hospitalized in Gentofte and Glostrup].
Isager H; Pedersen K
Ugeskr Laeger; 1966 Oct; 128(43):1286-7. PubMed ID: 5977325
[No Abstract] [Full Text] [Related]
[Next] [New Search]
